期刊文献+

碧罗芷体外抑制蛋白糖化终末产物生成作用的研究 被引量:3

Inhibitory effect of pycnogenol on generation of advanced glycation end products in vitro
下载PDF
导出
摘要 目的 应用体外蛋白糖化反应系统 ,确定碧萝芷抑制蛋白糖化终末产物生成的作用。方法 对照组将葡萄糖与牛血清白蛋白分别在 37、50、70℃共同孵育 ,实验组则加入不同剂量的碧萝芷或氨基胍。在不同时间取孵育样品用荧光分光光度计检测其荧光强度代表为蛋白糖化终末产物的生成量。结果 在本体外系统中 ,蛋白糖化产物的生成与孵育温度及时间呈正相关。碧萝芷在 0 3~ 2 0 g·L- 1 剂量范围内可有效抑制蛋白糖化终末产物的生成 ;其抑制作用相当于同剂量的氨基胍。 AIM To investigate the inhibitory effect of pycnogenol on generation of advanced glycation end products (AGEs) in vitro. METHODS Advanced glycation end products were determined by fluorospectrophotometer in the medium of 1 mol·L -1 glucose and 5% bovine albumin incubated at 37℃, 50℃, and 70℃ for different times. The inhibitory effect of pycnogenol was confirmed by the same system incubated with or without pycnogenol at different concentrations. RESULTS The rate of generation of AGEs in vitro was related with incubation time and incubation temperature. The generation of AGEs was inhibited by pycnogenol in vitro. The inhibitory rate was 10%~80% dependent on concentration and incubation time of pycnogenol. The inhibitory effect of pycnogenol on generation of AGEs was almost the same as that of Aminoguanidine at the same concentration. CONCLUSION pycnogenol could significantly inhibit generation of AGEs in vitro.
机构地区 卫生部北京医院
出处 《中国药理学通报》 CAS CSCD 北大核心 2003年第4期437-440,共4页 Chinese Pharmacological Bulletin
关键词 碧萝芷 蛋白糖化终末产物 抗氧化 氨基胍 pycnogenol advanced glycation end products(AGEs) antioxidant aminoguanidine
  • 相关文献

参考文献8

  • 1[1]Fu MX, Requena JR, Jenkins AJ et al. The advanced glycated end-product N-(carboxymethyl) lysine, is a product of both lipid peroxidation and glyoxidation reactions. J Biol Chem, 1996;271: 9982~6
  • 2[2]Nishikawa T, Edelstein D, Du XL et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemia induced damage. Nature, 2000;404: 787~9
  • 3[3]Blazso G, Gabor M, Sibbel R, Rohdewald P. Antiinflammatory and superoxide radical scavenging activities of a procyanidins containing extract from the bark of pinus pinaster aol and its fractions. Pharm Pharmacol Lett, 1994;3: 217~20
  • 4[4]Nelson AB, Lau BHS, Ide N, Rong Y. Pycnogenol inhibits macrophage oxidative burst, lipoprotein oxidation and hydroxyl redical induced DNA damage. Drug Dev Indust Med, 1998;24: 1~6
  • 5[5]Rumble JR, Cooper ME, Soulis T et al. Vascular hypertrophy in experimental diabetes--Role of advanced glycation end products. J Clin Invest, 1997;99: 1016~27
  • 6韩彩和,张铁梅.非酶糖化蛋白对体外培养血管内皮细胞生长的影响[J].中国糖尿病杂志,1999,7(2):89-90. 被引量:1
  • 7张铁梅,张延,韩彩和,金世鑫,迟家敏.糖化蛋白终末产物诱发糖尿病患者外周血淋巴细胞分泌TNF-α、IL-6的研究[J].中国糖尿病杂志,2001,9(2):72-75. 被引量:6
  • 8[8]Giardino I, Fard AK, Hatchell DL, Brownlee M. Aminoguanidine inhibit reactive oxygen species formation, lipid peroxidation and oxidant induced apoptosis. Diabetes, 1998;47:1114~7

二级参考文献3

共引文献5

同被引文献39

  • 1章剑今 王敏.银杏叶抗血栓及改善微循环作用的实验研究[J].中国中西医结合杂志,1995,15(5):320-320.
  • 2Arcangeli P. Pycnogenol R in chronic venous insufficiency[J]. Fitoterapia ,2000,71(3) :236.
  • 3Virgili F, Kim D, Packer L. Procyanidins extracted from pine bark protect α-tocopherol in ECV 304 endothelial cells challenged by activated RAW 264. 7 macrophages: role of nitric oxide and peroxynitrite[J].FEBS Lett , 1998,431(3): 315.
  • 4Saliou C, Rimbach G, Moini H, et al. Solar ultraviolet-induced erythema in human skin and nuclear factor-kappa-B-dependent gene expression in keratinocytes are modulated by a French maritime pine bark extract[J]. Free Radic Bio Med,2001,30(2):154.
  • 5Bayeta E, Lau B. Pycnogenol inhibits generation of inflammatory mediators in macrophages[J]. Nutr Res,2000,20(2):249.
  • 6Cheshier JE, Ardestani-Kaboudanian S, Liang B, et al. Immunomodulation by Pycnogenol R in retrovirus-infected or ethanol-fed mice[J].Life Sci, 1996, 58(5) :PL87.
  • 7Huynh H, Teel R. Effects of pycnogenol on the microsomal metabolism of the tobacco-specific nitrosamine NNK as a function of age [J].Cancer Lett, 1998,132(1 ~ 2): 135.
  • 8Peng Q, Buz' Zard A, Lau B. Pycnogenol R protects neurons from amyloid-β peptide-induced apoptosis[J]. Mol Brain Res ,2002,104(1) :55.
  • 9Veuaink G, Liu D,Taddei K, et al. Reduction of inclusion body pathology in ApoE-deficient mice fed a combination of antioxidants[J]. Free Radic Bio Med,2003,34(8): 1070.
  • 10Ohnishi S, Ohnishi T, Ogunmola G. Sickle cell anemia: a potential nutritional approach for a molecular disease[J]. Nutrition,2000, 16(5):330.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部